L-NORVALIN AND ISCHEMICAL PRECONDITIONING ACTION MECHANISMS ANALYSIS AT LIVER ISCHEMIA/REPERFUSION

Abstract

In this article ischemical preconditioning and L-norvalin efficacy and mechanisms of action pharmacological analysis at liver experimental ischemia/reperfusion were made. During investigation ischemical preconditioning high effectiveness totally wasn’t blocked by glibenclamide showed. L-norvaline also showed marked hepatoprotective effect abolished by glibenclamide just partly.

Keywords

ischemia / reperfusion / ischemical preconditioning / liver / L-norvalin

References

[1] Bolli R. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research / R. Bolli // J. Mol. Cell. Cardiol. - 2001. - Vol. 33. -Р. 1897-1918.

[2] Cohen, M.V. Adenosine: trigger and mediator of cardioprotection / M.V. Cohen, J.M. Downey // Basic. Res. Cardiol. -2008. - Vol. 103, № 3. - P. 203-215.

[3] Downey J.M. Signaling pathways in ischemic preconditioning / J.M. Downey, A.M. Davis, M.V. Cohen // Heart. Fail. Rev. - 2007. - Vol. 12. - P. 181-188.

[4] Kirino T. Ischemic tolerance / T. Kirino // J. Cerebr. Blood. Flow. Metabol. - 2002. - Vol. 22. - P. 1283-1296.

[5] Murry C.E. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium / С.Е. Murry, R.B. Jennings, К.А. Reimer // Circulation. -1986. - Vol. 14. - Р. 1124-1136.

[6] Rezkalla S.H. Preconditioning in humans / S.H. Rezkalla, R.A. Kloner // Heart. Fail. Rev. - 2007. - Vol. 12. - P. 201-206.

[7] Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis / Ran Meng [et al.] // Neurology. -2012. - Vol. 79. - P. 1853-1861.

RIGHTS & PERMISSIONS

Pokrovsky M.V., Lopatin D.V., Alehin S.A., Kolmykov D.I., Ivanova L.V., Lucenko V.D., Speransky S.L., Suhoterin I.V.